Skip to main content
SpringerLink
Log in

Modelos de simulación de eventos discretos: ¿por qué, cómo y cuándo?

  • Artículo de Investigación Original
  • Published:
PharmacoEconomics Spanish Research Articles

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Bibliografía

  1. Briggs AH, Sculpher M. An introduction to Markov modelling for economic evaluation. Pharmacoeconomics 1998; 13: 397–409.

    Article  PubMed  CAS  Google Scholar 

  2. Eddy D. Bringing health economic modelling to the 21st century. Value Health 2006; 9: 168–78.

    Article  PubMed  Google Scholar 

  3. Law A, Kelton W. Simulation modelling and analysis. 3rd edition. McGraw Hill: Boston 2000.

    Google Scholar 

  4. Banks J, Carson JS, Nelson BL. Discrete event system simulation. Englewood Cliffs: Prentice-Hall, 1996.

    Google Scholar 

  5. Stahl JE. Modelling methods for pharmacoeconomics and health technology assessment. An overview and guide. Pharmacoeconomics 2008; 26: 131–48.

    Article  PubMed  Google Scholar 

  6. Rodriguez Barrios JM, Serrano D, Monleón T, Caro J. Los modelos de simulación de eventos discretos en la evolución económica de tecnologías y productos sanitarios. Gac Sanit 2008; 22: 151–61.

    Article  PubMed  Google Scholar 

  7. Hollingworth W, Spackman E. Emerging methods in economic modeling of Imaging costs and outcomes: A short Report on discrete event simulation. Acad Radiol 2007; 14: 406–10.

    Article  PubMed  Google Scholar 

  8. Ramwadhdoebe S, Buskens E, Sakkers RUB, Stahl JE. A tutorial on discrete-event simulation for health policy design and decision making: optimizing paediatric ultrasound screening for hip dysplasia as an illustration. Health Policy 2009 (doi: 10.1016/j.healthpol.2009.07.007).

    Google Scholar 

  9. Caro JJ. Pharmacoeconomic analyses using discrete event simulation. Pharmacoeconomics 2005; 23: 323–32.

    Article  PubMed  Google Scholar 

  10. Karnon J. Alternative decision modelling techniques for the evaluation of healthcare technologies: Markov processes versus discrete event simulation. Health Econ 2003; 12: 837–48.

    Article  PubMed  Google Scholar 

  11. Simpson KN, Strassburger A, Jons WJ, Dietz B, Rajagopalan R. Comparison of Markov model and discrete-event simulation techniques for HIV. Pharmacoeconomics 2009; 27: 159–65.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Unidad Médica. Pfizer España, Dpto. de Investigación de Resultados en Salud y Farmacoeconomía, Avda de Europa 20-B, 28108, Alcobendas (Madrid), España

    Javier Soto Álvarez

Authors
  1. Javier Soto Álvarez
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Álvarez, J.S. Modelos de simulación de eventos discretos: ¿por qué, cómo y cuándo?. Pharmacoecon. Span. Res. Artic. 6, 83–89 (2009). https://doi.org/10.1007/BF03320854

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03320854

Search

Navigation